| Literature DB >> 35572380 |
Tyler G Saint-Denis1, Nelson Y S Lam1, Nikita Chekshin1, Paul F Richardson2, Jason S Chen3, Jeff Elleraas2, Kevin D Hesp4, Daniel C Schmitt4, Yajing Lian4, Chan Woo Huh4, Jin-Quan Yu1.
Abstract
Enantioselective C(sp3)-H activation has gained considerable attention from the synthetic chemistry community. Despite the intense interest in these reactions, the mechanisms responsible for enantioselection are still vague. In the course of the development of aryl thioether-directed C(sp3)-H arylation, we noticed extreme variation in sensitivity of two substrate classes to substituent effects of ligands and directing groups: whereas 3-pentyl sulfides (prochiral α-center) responded positively to substitution on ligands and directing groups, isobutyl sulfides (prochiral β-center) were entirely insensitive. Quantitative structure selectivity relationship (QSSR) analyses of directing group and ligand substitution and the development of a new class of mono-N-acetyl protected amino anilamide (MPAAn) ligands led to high enantiomeric ratios (up to 99:1) for thioether-directed C(sp3)-H arylation. Key to the realization of this method was the exploitation of transient chirality at sulfur, which relays stereochemical information from the ligand backbone to enantiotopic carbons of the substrate in a rate- and enantio-determining cyclometallation deprotonation. The absolute stereochemistry of the products for these two substrates were revealed to be opposite. DFT evaluation of all possible diastereomeric transition states confirmed initial premises that guided rational ligand and directing group design. The implications of this study will assist in the further development of enantioselective C(sp3)-H activation, namely by highlighting the non-innocence of directing groups, distal steric influences, and the delicate interplay between steric Pauli repulsion and London dispersion in enantioinduction.Entities:
Keywords: C–H activation; DFT; chiral sulfur; stereomodel; thioether
Year: 2021 PMID: 35572380 PMCID: PMC9098185 DOI: 10.1021/acscatal.1c02808
Source DB: PubMed Journal: ACS Catal Impact factor: 13.700